Home Search
pancreatic cancer - search results
If you're not happy with the results, please do another search
Trial demonstrates ARM-002TM vaccine’s effectiveness against pancreatic cancer
Defence Therapeutics has announced a successful pre-clinical vaccination trial utilising its ARM-002TM vaccine against pancreatic cancer.
Defence Therapeutics initiate testing of ARM vaccine against pancreatic cancer
Defence Therapeutics has mandated the Transbiotech Biotechnology Research and Transfer Center to begin testing its cellular anti-cancer ARM vaccine against pancreatic cancer.
Research from the...
The importance of sex differences in pancreatic cancer treatment
Researchers from Karolinska Institutet have found that certain immune cells in women with pancreatic cancer can obstruct their immune response.
The findings may explain differences...
Identifying pancreatic cancer up to three years early
Researchers discover a novel method of identifying pancreatic cancer up to three years early than current diagnoses.
In the largest study of its kind, researchers...
Researchers find method for improved pancreatic cancer treatment
A study from the Systems Oncology Lab at Champalimaud Research, published on September 9, has provided a potential solution to the issues surrounding pancreatic...
Social media – a powerful tool for elevating pancreatic cancer awareness
Pioneering research from Creation Healthcare illuminates that social media is an incredibly effective platform for driving pancreatic cancer awareness.
A new study investigating pancreatic cancer-related...
Scientists advance treatment for pancreatic cancer with new discovery
Effective new treatment for pancreatic cancer could be on the horizon thanks to researchers from Oregon State University, who have developed a new therapy...
Signs of pancreatic cancer detected with new AI technology
Researchers at Cedars-Sinai have created a cutting-edge Artificial Intelligence (AI) tool that can accurately diagnose early signs of pancreatic cancer.
The novel AI technology effectively...
Identifying patients at risk of pancreatic cancer using stool samples
A genetic signature of 27 microorganisms in stool samples can identify people at risk of pancreatic cancer.
A groundbreaking discovery by researchers in Spain, part-funded...
Prioritising investment and research into pancreatic cancer treatment
Chris Macdonald, Head of Research at Pancreatic Cancer UK explains why increased investment and research in pancreatic cancer treatment and symptoms are urgently needed.
Early...
Pancreatic cancer immunotherapy enhanced by new experimental drug
A team of researchers has identified a novel experimental drug that effectively boosts the efficacy of pancreatic cancer immunotherapy, potentially a landmark breakthrough in...
New biomarker identified to diagnose pancreatic cancer
A new biomarker – a protein called pentraxin 3 (PTX3) – has been identified that could be used to aid in the diagnosis of...
AI-based tool could improve pancreatic cancer research and treatment
A new artificial-intelligence-based tool has been developed to predict genomic subtypes of pancreatic cancer.
The innovation is a collaboration between AP-HP Greater Paris University Hospitals...
Study shows potential for earlier pancreatic cancer diagnosis
Machine learning could aid an earlier pancreatic cancer diagnosis and increase patient survival numbers, new research has found.
A study, led by the London School...
Pancreatic cancer treatment improved by suppressing molecular pathway
Chemotherapy for pancreatic cancer patients may be enhanced due to the discovery of a molecular pathway that enables resistance to the treatment.
The investigation, conducted...
Calls for investment to reduce pancreatic cancer deaths in Europe
Researchers are calling on European policymakers to invest adequate resources to tackle pancreatic cancer in Europe.
There have been limited advancements in the treatment of...
Early diagnosis of pancreatic cancer and challenges during COVID-19
Beth Rice, Health and Policy Manager at Pancreatic Cancer Action, discusses the challenges facing the treatment and diagnosis of pancreatic cancer during the COVID-19...
Why we need to begin prioritising pancreatic cancer
Professor Matthias Löhr, a member of the UEG Public Affairs Committee, explains why increased awareness of pancreatic cancer and increased investment into the field...
Colorectal and pancreatic cancer on the rise worldwide
Incidence rates for colorectal cancer and fatality rates for pancreatic cancer have both increased by around 10% worldwide since 1990
Incidence rates for colorectal cancer...
Black Swan: rare Jamaican cannabis strain could treat pancreatic cancer
In 2019 a flavonoid of cannabis – Caflanone (FBL-03G) – was granted Orphan drug status by the United States Food and Drug Administration. Now,...